Credit Suisse’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $765K | Buy |
58,631
+240
| +0.4% | +$3.13K | ﹤0.01% | 2421 |
|
|
2023
Q4 | $744K | Buy |
58,391
+8,808
| +18% | +$112K | ﹤0.01% | 2524 |
|
|
2023
Q3 | $650K | Buy |
49,583
+1,662
| +3% | +$21.8K | ﹤0.01% | 2534 |
|
|
2023
Q2 | $1.23M | Buy |
47,921
+28,498
| +147% | +$729K | ﹤0.01% | 2234 |
|
|
2023
Q1 | $489K | Buy |
19,423
+2,131
| +12% | +$53.7K | ﹤0.01% | 2746 |
|
|
2022
Q4 | $398K | Buy |
17,292
+4,071
| +31% | +$93.6K | ﹤0.01% | 2895 |
|
|
2022
Q3 | $291K | Buy |
13,221
+161
| +1% | +$3.54K | ﹤0.01% | 3080 |
|
|
2022
Q2 | $187K | Buy |
13,060
+2,524
| +24% | +$36.1K | ﹤0.01% | 3340 |
|
|
2022
Q1 | $199K | Buy |
+10,536
| New | +$199K | ﹤0.01% | 3357 |
|